| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |